News

News

Market Focus: Digging Into Shares of Retail Properties of America, Inc. (NYSE:RPAI) as they hit $13.91

Investors might be trying to gauge which way shares of Retail Properties of America, Inc. (NYSE:RPAI) will swing over the next couple of quarters. In recent trading activity, the stock has been seen near the $13.91 level. Many investors pay increased attention to shares when they are nearing notable historical […]

by × December 6, 2019 × 0 comments

News

Are Firms & Funds Taking More Interest in SBA Communications Corporation (NASDAQ:SBAC)?

In the SEC’s latest filings, institutions owning shares of SBA Communications Corporation (NASDAQ:SBAC) have increased their transactions by 0.74%.  Institutions now own 97.40% of the company. Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings […]

by × December 6, 2019 × 0 comments

News

Indicator Watch: F Score Five or Higher for Mid-Con Energy Partners L.P. (MCEP)

Watching the signals for Mid-Con Energy Partners L.P. (MCEP), we have recently spotted that the Piotroski F Score is five or higher. Investors may be looking at this score as a sign of strong financial strength. Investing in the stock market often requires individuals to gauge how much risk they […]

by × December 6, 2019 × 0 comments

News

F Score Reading in Focus for NewMarket Corp. (NEU)

Viewing the technicals on shares of NewMarket Corp. (NEU), we note that the Piotroski F Score is currently at five or above. Traders may be following the score looking for signs of possible strength. When dealing with the stock market, investors have to be constantly on their toes. Investors who […]

by × December 6, 2019 × 0 comments

News

What’s Behind the Numbers For Eidos Therapeutics, Inc. (NasdaqGS:EIDX) as VC2 Runs to 85?

Developed by James O’Shaughnessy, the Value Composite score uses six valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, price to sales and shareholder yield.  Eidos Therapeutics, Inc. (NasdaqGS:EIDX) has a Value Composite score of 85. The VC score is displayed […]

by × December 6, 2019 × 0 comments